Literature DB >> 24085817

Emergence of carbapenem-resistant Acinetobacter baumannii in hospitals in Pakistan.

Badrul Hasan1, Khalida Perveen2, Björn Olsen1, Rabaab Zahra2.   

Abstract

The emergence of pan-resistance in bacterial pathogens poses a threat to human health. Carbapenem-resistant Acinetobacter baumannii has emerged as a serious challenge, causing nosocomial infection and community-acquired outbreaks in hospitals globally, including in Pakistan. We collected 90 Acinetobacter isolates from patients with secondary or nosocomial infections from different hospitals in Pakistan and screened for carbapenem-resistant strains. Of the 90 isolates, 59 were resistant to carbapenems. Among oxacillinase -encoding genes, blaOXA-51-like was common in all isolates, including in combination with blaOXA-23-like in 14 isolates; however, blaOXA-24-like and blaOXA-58-like were completely absent. Among metallo-β-lactamase-encoding genes, only blaNDM-1 was found in one isolate, while the other three genes, blaIMP, blaVIM and blaSIM, were completely absent. None of the isolates was found to harbour the blaCTX-M gene. The isolates were also tested for susceptibilities to a panel of different antibiotics belonging to several classes. Of all the drugs tested, tigecycline was the most effective with 80 % sensitivity amongst isolates, followed by colistin with 50 % sensitivity. Three categories of resistance were found in these isolates: extreme drug resistance in 26, pan-drug resistance in 19 and multidrug resistance in 87 isolates. The isolates exhibited a high resistance to cephalosporins, trimethoprim-sulfamethoxazole and β-lactam antibiotics, followed by tetracycline and β-lactam/β-lactam inhibitor combination, fluoroquinolone and aminoglycosides. The results show a prominent level of antibiotic-resistance phenotypes in A. baumannii and strongly suggest the need for full-scale national surveillance of carbapenem-resistant A. baumannii with particular emphasis on the newly identified NDM-1 (New Delhi metallo-β-lactamase-1).

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24085817     DOI: 10.1099/jmm.0.063925-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  25 in total

1.  Management of Intra-abdominal Infections due to Carbapenemase-Producing Organisms.

Authors:  Paola Di Carlo; Francesco Vitale; Criostóir O'Súilleabháin; Alessandra Casuccio
Journal:  Curr Infect Dis Rep       Date:  2014-10       Impact factor: 3.725

2.  Molecular Methods for Identification of Acinetobacter Species by Partial Sequencing of the rpoB and 16S rRNA Genes.

Authors:  Azar Dokht Khosravi; Parisa Sadeghi; Abdolrazagh Hashemi Shahraki; Parvin Heidarieh; Nasrin Sheikhi
Journal:  J Clin Diagn Res       Date:  2015-07-01

Review 3.  Carbapenem-Resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast Asia.

Authors:  Li-Yang Hsu; Anucha Apisarnthanarak; Erum Khan; Nuntra Suwantarat; Abdul Ghafur; Paul Anantharajah Tambyah
Journal:  Clin Microbiol Rev       Date:  2016-10-19       Impact factor: 26.132

4.  Acinetobacter baumannii response to host-mediated zinc limitation requires the transcriptional regulator Zur.

Authors:  Brittany L Mortensen; Subodh Rathi; Walter J Chazin; Eric P Skaar
Journal:  J Bacteriol       Date:  2014-05-09       Impact factor: 3.490

5.  Genetic diversity of OXA-51-like genes among multidrug-resistant Acinetobacter baumannii in Riyadh, Saudi Arabia.

Authors:  M Aly; H T Tayeb; S M Al Johani; E J Alyamani; F Aldughaishem; I Alabdulkarim; H H Balkhy
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-02-10       Impact factor: 3.267

6.  Intravenous Colistin in the treatment of multidrug-resistant Acinetobacter in neonates.

Authors:  Manar Al-Lawama; Haytham Aljbour; Asma Tanash; Eman Badran
Journal:  Ann Clin Microbiol Antimicrob       Date:  2016-02-12       Impact factor: 3.944

7.  Antibiogram of Medical Intensive Care Unit at Tertiary Care Hospital Setting of Pakistan.

Authors:  Aayesha Qadeer; Aftab Akhtar; Qurat Ul Ain; Shoab Saadat; Salman Mansoor; Salman Assad; Wasib Ishtiaq; Abid Ilyas; Ali Y Khan; Yousaf Ajam
Journal:  Cureus       Date:  2016-09-29

8.  Molecular Epidemiology of Extensively-Drug Resistant Acinetobacter baumannii Sequence Type 2 Co-Harboring bla NDM and bla OXA From Clinical Origin.

Authors:  Hasan Ejaz; Mahtab Ahmad; Sonia Younas; Kashaf Junaid; Khalid Omer Abdalla Abosalif; Abualgasim Elgaili Abdalla; Ayman Ali Mohammed Alameen; Mohammed Yagoub Mohammed Elamir; Syed Nasir Abbas Bukhari; Naveed Ahmad; Muhammad Usman Qamar
Journal:  Infect Drug Resist       Date:  2021-05-25       Impact factor: 4.003

9.  Compassionate use of cefiderocol for carbapenem-resistant Acinetobacter baumannii prosthetic joint infection.

Authors:  Diana A Mabayoje; Caoimhe NicFhogartaigh; Benny P Cherian; Mei Gie Meiqi Tan; David W Wareham
Journal:  JAC Antimicrob Resist       Date:  2021-06-15

10.  Prevalence of Genes of OXA-23 Carbapenemase and AdeABC Efflux Pump Associated with Multidrug Resistance of Acinetobacter baumannii Isolates in the ICU of a Comprehensive Hospital of Northwestern China.

Authors:  Wei Jia; Caiyun Li; Haiyun Zhang; Gang Li; Xiaoming Liu; Jun Wei
Journal:  Int J Environ Res Public Health       Date:  2015-08-21       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.